<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Trauma and Orthopaedic Surgery Articles</title>
<copyright>Copyright (c) 2013 Royal College of Surgeons in Ireland All rights reserved.</copyright>
<link>http://epubs.rcsi.ie/tosart</link>
<description>Recent documents in Trauma and Orthopaedic Surgery Articles</description>
<language>en-us</language>
<lastBuildDate>Sat, 26 Jan 2013 22:29:36 PST</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Assessment of a new undergraduate module in musculoskeletal medicine.</title>
<link>http://epubs.rcsi.ie/tosart/4</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/tosart/4</guid>
<pubDate>Mon, 15 Oct 2012 05:04:28 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Despite the high prevalence of musculoskeletal disorders seen by primary care physicians, numerous studies have demonstrated deficiencies in the adequacy of musculoskeletal education at multiple stages of medical education. The aim of this study was to assess a newly developed module in musculoskeletal medicine for use at European undergraduate level (i.e., the medical-school level).</p>
<p>METHODS: A two-week module in musculoskeletal medicine was designed to cover common musculoskeletal disorders that are typically seen in primary care. The module incorporated an integrated approach, including core lectures, bedside clinical examination, and demonstration of basic practical procedures. A previously validated examination in musculoskeletal medicine was used to assess the cognitive knowledge of ninety-two students on completion of the module. A historical control group (seventy-two students) from a prior course was used for comparison.</p>
<p>RESULTS: The new module group (2009) performed significantly better than the historical (2006) control group in terms of score (62.3% versus 54.3%, respectively; p < 0.001) and pass rate (38.4% versus 12.5%, respectively; p = 0.0002). In a subgroup analysis of the new module group, students who enrolled in the graduate entry program (an accelerated four-year curriculum consisting of students who have already completed an undergraduate university degree) were more likely to perform better in terms of average score (72.2% versus 57%, respectively; p < 0.001) and pass rates (70.9% versus 21.4%, respectively; p < 0.001) compared with students who had enrolled via the traditional undergraduate route. In terms of satisfaction rates, the new module group reported a significantly higher satisfaction rate than that reported by the historical control group (63% versus 15%, respectively; p < 0.001).</p>
<p>CONCLUSIONS: In conclusion, the musculoskeletal module described in this paper represents an educational advance at undergraduate (i.e., medical-school) level as demonstrated by the improvement in scores in a validated examination. As pressure on medical curricula grows to accommodate advancing medical knowledge, it is important to continue to improve, assess, and consolidate the position of musculoskeletal medicine in contemporary medical education.</p>

	]]>
</description>

<author>Joseph M. Queally et al.</author>


<category>Curriculum</category>

<category>Education, Medical, Undergraduate</category>

<category>Educational Measurement</category>

<category>Ireland</category>

<category>Musculoskeletal Diseases</category>

<category>Teaching</category>

</item>






<item>
<title>Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis.</title>
<link>http://epubs.rcsi.ie/tosart/3</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/tosart/3</guid>
<pubDate>Mon, 12 Dec 2011 04:44:36 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Osteoporosis, a disease of decreased bone mineral density represents a significant and growing burden in the western world. Aging population structure and therapeutic use of glucocorticoids have contributed in no small way to the increase in the incidence of this disease. Despite substantial investigative efforts over the last number of years the exact molecular mechanism underpinning the initiation and progression of osteoporosis remain to be elucidated. This has meant that no significant advances in therapeutic strategies have emerged, with joint replacement surgery being the mainstay of treatment.</p>
<p>METHODS: In this study we have used an integrated genomics profiling and computational biology based strategy to identify the key osteoblast genes and gene clusters whose expression is altered in response to dexamethasone exposure. Primary human osteoblasts were exposed to dexamethasone in vitro and microarray based transcriptome profiling completed.</p>
<p>RESULTS: These studies identified approximately 500 osteoblast genes whose expression was altered. Functional characterization of the transcriptome identified developmental networks as being reactivated with 106 development associated genes found to be differentially regulated. Pathway reconstruction revealed coordinate alteration of members of the WNT signaling pathway, including frizzled-2, frizzled-7, DKK1 and WNT5B, whose differential expression in this setting was confirmed by real time PCR.</p>
<p>CONCLUSION: The WNT pathway is a key regulator of skeletogenesis as well as differentiation of bone cells. Reactivation of this pathway may lead to altered osteoblast activity resulting in decreased bone mineral density, the pathological hallmark of osteoporosis. The data herein lend weight to the hypothesis that alterations in developmental pathways drive the initiation and progression of osteoporosis.</p>

	]]>
</description>

<author>Conor J. Hurson et al.</author>


<category>Apoptosis</category>

<category>Bone Development</category>

<category>Cells, Cultured</category>

<category>Dexamethasone</category>

<category>Gene Expression</category>

<category>Gene Expression Profiling</category>

<category>Glucocorticoids</category>

<category>Humans</category>

<category>Oligonucleotide Array Sequence Analysis</category>

<category>Osteoblasts</category>

<category>Osteoporosis</category>

<category>Oxidative Stress</category>

<category>Signal Transduction</category>

<category>Wnt Proteins</category>

</item>






<item>
<title>An application of principal component analysis to the clavicle and clavicle fixation devices.</title>
<link>http://epubs.rcsi.ie/tosart/2</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/tosart/2</guid>
<pubDate>Thu, 01 Dec 2011 07:50:25 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Principal component analysis (PCA) enables the building of statistical shape models of bones and joints. This has been used in conjunction with computer assisted surgery in the past. However, PCA of the clavicle has not been performed. Using PCA, we present a novel method that examines the major modes of size and three-dimensional shape variation in male and female clavicles and suggests a method of grouping the clavicle into size and shape categories.</p>
<p>MATERIALS AND METHODS: Twenty-one high-resolution computerized tomography scans of the clavicle were reconstructed and analyzed using a specifically developed statistical software package. After performing statistical shape analysis, PCA was applied to study the factors that account for anatomical variation.</p>
<p>RESULTS: The first principal component representing size accounted for 70.5 percent of anatomical variation. The addition of a further three principal components accounted for almost 87 percent. Using statistical shape analysis, clavicles in males have a greater lateral depth and are longer, wider and thicker than in females. However, the sternal angle in females is larger than in males. PCA confirmed these differences between genders but also noted that men exhibit greater variance and classified clavicles into five morphological groups.</p>
<p>DISCUSSION AND CONCLUSIONS: This unique approach is the first that standardizes a clavicular orientation. It provides information that is useful to both, the biomedical engineer and clinician. Other applications include implant design with regard to modifying current or designing future clavicle fixation devices. Our findings support the need for further development of clavicle fixation devices and the questioning of whether gender-specific devices are necessary.</p>

	]]>
</description>

<author>Zubin J. Daruwalla et al.</author>


</item>






<item>
<title>Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation</title>
<link>http://epubs.rcsi.ie/tosart/1</link>
<guid isPermaLink="true">http://epubs.rcsi.ie/tosart/1</guid>
<pubDate>Tue, 22 Feb 2011 07:57:54 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: The Wnt/β-catenin pathway is a major signaling cascade in bone biology, playing a key role in bone development and remodeling. The objectives of this study were firstly, to determine the effects of dexamethasone exposure on Wnt/β-catenin signaling at an intracellular and transcriptional level, and secondly, to assess the phenotypic effects of silencing the Wnt antagonist, Dickkopf-1 (Dkk1) in the setting of dexamethasone exposure. METHODS: Primary human osteoblasts were exposed in vitro to 10-8 M dexamethasone over a 72 h time course. The phenotypic marker of osteoblast differentiation was analyzed was alkaline phosphatase activity. Intracellular β-catenin trafficking was assessed using immunoflourescence staining and TCF/LEF mediated transcription was analyzed using a Wnt luciferase reporter assay. Dkk1 expression was silenced using small interfering RNA (siRNA). RESULTS: Primary human osteoblasts exposed to dexamethasone displayed a significant reductions in alkaline phosphatase activity over a 72 h time course. Immunoflourescence analaysis of β-catenin localization demonstrated a significant reduction in intracytosolic and intranuclear β-catenin in response to dexamethasone exposure. These changes were associated with a reduction of TCF/LEF mediated transcription. Silencing Dkk1 expression in primary human osteoblasts exposed to dexamethasone resulted in an increase in alkaline phosphatase activity when compared to scrambled control. CONCLUSIONS: Wnt/β-catenin signaling plays a key role in regulating glucocorticoid-induced osteoporosis in vitro. Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. Targeting of the Wnt/β-catenin signaling pathway offers an exciting opportunity to develop novel anabolic bone agents to treat osteoporosis and disorders of bone mass.</p>

	]]>
</description>

<author>Joseph S. Butler et al.</author>


</item>





</channel>
</rss>
